Oral, Oropharyngeal & Salivary Gland Cancers | National Institute of Dental and Craniofacial Research

Skip to main content

Oral, Oropharyngeal & Salivary Gland Cancers

Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

PA-20-272

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required)

PAR-20-305

Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)

PA-20-135

Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

PAR-20-277

Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

PAR-20-276

Administrative Supplement for Research on Dietary Supplements (Admin Supp-Clinical Trial Not Allowed)

PA-20-227

Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)

PA-18-935

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

PAR-20-155

4DN Organization and Function in Human Health and Disease (U01 Clinical Trial Not Allowed)

RFA-RM-20-005

The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)

RFA-OD-19-029